2015
DOI: 10.1016/j.tjog.2014.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal diagnosis and array comparative genomic hybridization characterization of trisomy 21 in a fetus associated with right congenital diaphragmatic hernia and a review of the literature of chromosomal abnormalities associated with congenital diaphragmatic hernia

Abstract: Prenatal diagnosis of right CDH should raise a suspicion of chromosomal abnormalities especially trisomy 21 and the association of Morgagni hernia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…Previously used methods, such as karyotyping and different types of gene dose arrays, have recently been replaced by different massive parallel sequencing (MPS) approaches. [23][24][25][26] were collected. There were 83 active participating centers that reported to the registry (specified in the Appendix) that includes prospectively collected information on newborns with CDH until death or discharge.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previously used methods, such as karyotyping and different types of gene dose arrays, have recently been replaced by different massive parallel sequencing (MPS) approaches. [23][24][25][26] were collected. There were 83 active participating centers that reported to the registry (specified in the Appendix) that includes prospectively collected information on newborns with CDH until death or discharge.…”
Section: Introductionmentioning
confidence: 99%
“…Genetic testing, both prenatal and postnatal, has evolved during the years. Previously used methods, such as karyotyping and different types of gene dose arrays, have recently been replaced by different massive parallel sequencing (MPS) approaches 23–26 . MPS in modern clinical genetic practice includes either exome sequencing or genome sequencing technologies.…”
Section: Introductionmentioning
confidence: 99%